DuPont has announced that it will highlight DuPont Liveo Healthcare Solutions – with an emphasis on the brand’s medical device product lines – at MD&M West 2023, which will take place 7th-9th February in Anaheim, California, USA.
In Booth 3207, DuPont will feature its product portfolio – including new low-cyclic soft skin adhesive – and highlight medical device product partnerships, notably:
- Nighthawk wearable patch – A collaboration with the Holst Centre that leverages the expanding portfolio of DuPont Liveo medical adhesives and sensing technologies to support the development of a wearable concept patch especially designed to improve wearability and long-term comfort, enhancing the patient experience while recording electrical signals for vital signs and physiological parameters.
- AeviceMD smart stethoscope – A collaboration with Aevice Health Pte to support the development of a smart AI wearable stethoscope that provides continuous, connected care for at-home monitoring and early detection of asthma exacerbation (commonly referred to as an “asthma attack”) in patients.
“From concepting to commercialisation, we support an ecosystem of medical device partners and work with them to create smarter next-generation devices,” said Liveo Healthcare Solutions Americas marketing leader, Diana Salvadori. “Whether customers are looking for technological expertise; regulatory support; or a broad selection of high-quality, medical-grade materials that are easy to process and patient-friendly, DuPont serves a broad spectrum of medical device applications.”
DuPont is introducing new Liveo MG 7-9960 Soft Skin Adhesive, a soft elastomeric silicone adhesive for adhering medical devices to the skin with high adhesion force, long wear time and gentle removal. The product has been designed with low content cyclosiloxanes.
“We’re actively working to expand our portfolio of solutions to help customers meet challenging application demands for connected wearable devices,” Salvadori said.
DuPont’s medical device development partnerships and continued investments in its product portfolio and manufacturing expansion cement the company’s commitment to serving the healthcare market by offering high-quality, high-performance solutions; application and material science expertise; and strong regulatory support.